Atlas Trials

Real World Study of the Effectiveness and Safety of Conbercept Ophthalmic Injection in the Treatment of Retinopathy of Prematurity - Multicenter, Retrospective and Observational Study Based on Real World Data

Clinical trial NCT04985448 · UNKNOWN

Trial details

NCT number
NCT04985448
Sponsor
Chengdu Kanghong Biotech Co., Ltd.
Status
UNKNOWN
Study type
OBSERVATIONAL
Retinopathy of Prematurity
Start date
2022-09-01
Primary completion
2022-10-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.